News

Project milestone: the MOSAIC study reaches 1,000 patients

MOSAIC surpasses 1,000 patients across 7 cancers and 6 data modalities, capturing tumor complexity at scale.

October 9, 2024

We’re excited to announce we have now exceeded 1,000 patients with our partnering cancer research hospitals across Europe and the US.

Unlike similar studies, MOSAIC is both broad and deep, covering 7 cancer indications and 6 data modalities, including clinical and longitudinal data. By using 10XGenomics single-cell and spatial technologies on whole tissue sections, MOSAIC fully captures TME heterogeneity.

We believe that the synergy of large scale spatial omics data and AI will help us decode cancer complexity.

About MOSAIC

MOSAIC is a large-scale initiative that combines patient samples and technologies from multiple institutions, hospitals and technology partners, who are joining forces with Owkin to create the largest multimodal, spatial omics atlas in cancer.

More information

More like this

News

September 15, 2025

The MOSAIC Window dataset is now fully available

Access 60 patients from MOSAIC’s 7,000-patient dataset to explore spatial omics and validate research ideas.

News

May 27, 2025

MOSAIC: Intra-tumoral heterogeneity characterization through large-scale spatial and cell-resolved multi-omics profiling

Our latest publication on spatial and single-cell omics, histology, and AI.